Together, these data support a FGF-2-induced conversion of B cells into a tumor-supportive phenotype which, with IGF-1 as critical key growth factor, reciprocally provides sustained pro-inflammatory and pro-tumorigenic signals to melanoma cells leading to activation of FGFR-3 (Fig. 3i). This evidence concerns the gene IGF1 and melanoma.